We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+3.39%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$374M
AUM Growth
+$74.3M
(+25%)
Cap. Flow
+$61.2M
Cap. Flow
% of AUM
16.36%
Top 10 Holdings %
Top 10 Hldgs %
71.35%
Holding
76
New
20
Increased
32
Reduced
15
Closed
2
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$16.8M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$12.8M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$2.21M |
| 4 |
ZVO
Zovio Inc. Common Stock
ZVO
|
+$1.63M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$1.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$5.69M |
| 2 |
State Street SPDR S&P Dividend ETF
SDY
|
+$3.89M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$1.01M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$903K |
| 5 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$728K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 96.42% |
| 2 | Healthcare | 1.76% |
| 3 | Consumer Staples | 0.65% |
| 4 | Materials | 0.42% |
| 5 | Technology | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Neurocrine Biosciences
NBIX
$13.9B
| $406K | 0.11% |
27,365
| – | – |
2013 Q4
2 quarters
|
|
|
ARNA
52
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $387K | 0.1% |
+6,612
| New | +$416K |
2014 Q2
0 quarters
|
|
|
IPCM
53
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $367K | 0.1% |
+8,293
| New | +$361K |
2014 Q2
0 quarters
|
|
54
WisdomTree US LargeCap Dividend Fund
DLN
$6.31B
| $296K | 0.08% |
8,354
| – | – |
2013 Q2
4 quarters
|
|
55
Illumina
ILMN
$40.5B
| $284K | 0.08% |
1,637
| – | – |
2014 Q1
1 quarter
|
|
56
Vanguard Real Estate ETF
VNQ
$36.7B
| $278K | 0.07% |
3,721
+120
| +3% | +$8.82K |
2013 Q4
2 quarters
|
|
57
Tesla
TSLA
$1.43T
| $275K | 0.07% |
+17,175
| New | +$240K |
2014 Q2
0 quarters
|
|
58
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.6B
| $243K | 0.07% |
+2,396
| New | +$243K |
2014 Q2
0 quarters
|
|
59
Qualcomm
QCOM
$191B
| $222K | 0.06% |
+2,809
| New | +$223K |
2014 Q2
0 quarters
|
|
60
Vanguard Total World Stock ETF
VT
$82.1B
| $216K | 0.06% |
+3,478
| New | +$211K |
2014 Q2
0 quarters
|
|
|
TLRA
61
DELISTED
Telaria, Inc.
TLRA
| $202K | 0.05% |
42,828
| – | – |
2014 Q1
1 quarter
|
|
62
Coeur Mining
CDE
$15.8B
| $156K | 0.04% |
+17,000
| New | +$140K |
2014 Q2
0 quarters
|
|
63
DELISTED
Assertio
ASRT
| $139K | 0.04% |
+167
| New | +$129K |
2014 Q2
0 quarters
|
|
64
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – |
0
| – | – |
2014 Q2
0 quarters
|
|
65
Kinross Gold
KGC
$28.3B
| $81K | 0.02% |
19,500
| – | – |
2014 Q1
1 quarter
|
|
66
Hecla Mining
HL
$10.5B
| $52K | 0.01% |
15,000
+5,000
| +50% | +$15.3K |
2014 Q1
1 quarter
|
|
67
DELISTED
Reeds, Inc. Common Stock
REED
| $52K | 0.01% |
+200
| New | +$50.5K |
2014 Q2
0 quarters
|
|
|
WILN
68
DELISTED
Wi-LAN Inc.
WILN
| $32K | 0.01% |
+10,000
| New | +$30.7K |
2014 Q2
0 quarters
|
|
69
Solitario Resources
XPL
$48.8M
| $29K | 0.01% |
22,000
-3,000
| -12% | -$3.61K |
2014 Q1
1 quarter
|
|
|
AXU
70
DELISTED
Alexco Resource Corp
AXU
| $22K | 0.01% |
17,500
+5,000
| +40% | +$6.36K |
2013 Q4
2 quarters
|
|
71
DELISTED
Eurasian Minerals Inc
EMXX
| $18K | ﹤0.01% |
+22,543
| New | +$19.5K |
2014 Q2
0 quarters
|
|
72
Paramount Gold Nevada
PZG
$91.4M
| $13K | ﹤0.01% |
+13,085
| New | +$13.5K |
2014 Q2
0 quarters
|
|
|
CFN
73
DELISTED
CAREFUSION CORPORATION
CFN
| $7K | ﹤0.01% |
+32,861
| New | +$1.36M |
2014 Q2
0 quarters
|
|
74
Comstock
LODE
$144M
| – | – |
-60
| Closed | -$25K | – |
|
|
75
State Street Blackstone Senior Loan ETF
SRLN
$5.39B
| – | – |
-14,552
| Closed | -$728K | – |
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Callan Capital held 76 positions worth $374M, up 25% from $300M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Callan Capital deployed $61.2M of net new capital in Q2 2014, opening 20 new positions and adding to 32 existing holdings. Its largest new stake was Xtrackers MSCI EAFE Hedged Equity ETF: 610,665 shares worth $16.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, down from 98% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Invesco FTSE RAFI US 1000 ETF, an estimated $5.69M trimmed.
- Callan Capital's largest Q2 2014 buy was Xtrackers MSCI EAFE Hedged Equity ETF: 610,665 shares worth $16.9M.
- Callan Capital added most to RECEPTOS INC COM STK (DE) in Q2 2014, an estimated $12.8M increase.
- Callan Capital's biggest Q2 2014 reduction was Invesco FTSE RAFI US 1000 ETF, cutting an estimated $5.69M.
- Callan Capital fully exited State Street Blackstone Senior Loan ETF in Q2 2014, selling an estimated $728K.
- Callan Capital's ten largest holdings make up 71% of its $374M portfolio in Q2 2014.
- Callan Capital opened 20 new positions and closed 2 in Q2 2014.
- Callan Capital's portfolio value rose 25% quarter-over-quarter to $374M.
Based on Callan Capital's 13F filing for Q2 2014, filed 13 Aug 2014.